We use cookies to make your experience better.
To comply with the new privacy directive, we need to ask for your consent to set the cookies.
Learn more
Accept
Reject
Menu
Search
Home
R&D
Science & Reports
Latest Articles
Our Company
Board of Management & Directors
Management & Advisors
Our Company
Investors
Investor Welcome
Share Registry
Corporate Governance
Announcements
Contact Us
Contact Us
Privacy Policy
Cookies Policy
Announcements
Home
>
Investors
>
Announcements
Investor Welcome
Share Registry
Corporate Governance
Announcements
Announcements
5-Jul-2024
Myopharm® Company Update: Appointment of Dr Richard Mollard
20-Mar-2024
American Diabetes Association® invites Myopharm® to profile pioneering work on TriGlytza™
4-Mar-2024
Myopharm® Company Update and Bioshares Report
12-Dec-2023
Myopharm® Completes the Purchase of TriGlytza™
20-Jul-2023
Signs Non-Binding Agreement to Purchase TriGlytza™
16-Jun-2023
Myopharm Strengthens Licensing Pipeline
4-May-2023
Myopharm Board of Directors appointment Mr Tsutomu (Tom) Abe
17-Feb-2023
Licence Agreement with BIO-E Australia Pty Ltd
8-Feb-2023
Acquisition of Omni Innovation Pty Limited Completed
1